Federal Court of Australia
FEDERAL COURT OF AUSTRALIA
Bayer Pharma Aktiengesellschaft v Generic Health Pty Ltd [2017] FCA 428 File number(s): NSD 236 of 2012
Judge(s): JAGOT J
Date of judgment: 4 May 2017
Catchwords: COSTS – damages for patent infringement – offer of compromise made – whether respondent sufficiently informed whether the offer represented a genuine compromise – indemnity basis
Legislation: Patents Act 1990 (Cth) s 115 Federal Court Rules 2011 (Cth) rr 1.35; 25.14
Cases cited: Bayer Pharma Aktiengesellschaft v Generic Health Pty Ltd [2017] FCA 250 Bayer Pharma Aktiengesellschaft v Generic Health Pty Ltd [2012] FCA 1510; (2012) 99 IPR 59 Futuretronics.com.au Pty Ltd v Graphix Labels Pty Ltd [2009] FCAFC 40
Date of hearing: 20 April 2017
Registry: New South Wales
Division: General Division
National Practice Area: Intellectual Property
Sub-area: Patents and associated Statutes
Category: Catchwords
Number of paragraphs: 10
Counsel for the Applicants: D Shavin QC with H Rofe QC
Solicitor for the Applicants: Davies Collison Cave Law
Counsel for the Respondents: I Jackman SC with DB Larish
Solicitor for the Respondents: Bird & Bird
ORDERS NSD 236 of 2012
BETWEEN: BAYER PHARMA AKTIENGESELLSCHAFT First Applicant
BAYER AUSTRALIA LTD (ACN 000 138 714) Second Applicant
AND: GENERIC HEALTH PTY LTD (ACN 110 617 859) First Respondent
LUPIN AUSTRALIA PTY LTD (ACN 112 038 105) Second Respondent
JUDGE: JAGOT J DATE OF ORDER: 4 MAY 2017
We try to embed the page this law was scraped from. If the site blocks framing, you still get the link and a local excerpt.
Last checked with source on —
Checking whether the official page can be embedded…
Plain-English simplify of this law: a short summary, key points, and both sides of the argument. Generated on first view via Replicate, then cached. Vote on what helps your study.
No study brief is cached for this law yet. Sign up to generate a plain-English brief.
Sign up to generate